» Articles » PMID: 29997290

Chikungunya Virus Impairs Draining Lymph Node Function by Inhibiting HEV-mediated Lymphocyte Recruitment

Overview
Journal JCI Insight
Date 2018 Jul 13
PMID 29997290
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Chikungunya virus (CHIKV) causes acute and chronic rheumatologic disease. Pathogenic CHIKV strains persist in joints of immunocompetent mice, while the attenuated CHIKV strain 181/25 is cleared by adaptive immunity. We analyzed the draining lymph node (dLN) to define events in lymphoid tissue that may contribute to CHIKV persistence or clearance. Acute 181/25 infection resulted in dLN enlargement and germinal center (GC) formation, while the dLN of mice infected with pathogenic CHIKV became highly disorganized and depleted of lymphocytes. Using CHIKV strains encoding ovalbumin-specific TCR epitopes, we found that lymphocyte depletion was not due to impaired lymphocyte proliferation. Instead, the accumulation of naive lymphocytes transferred from the vasculature to the dLN was reduced, which was associated with fewer high endothelial venule cells and decreased CCL21 production. Following NP-OVA immunization, NP-specific GC B cells in the dLN were decreased during pathogenic, but not attenuated, CHIKV infection. Our data suggest that pathogenic, persistent strains of CHIKV disable the development of adaptive immune responses within the dLN.

Citing Articles

A specific gene expression program underlies antigen archiving by lymphatic endothelial cells in mammalian lymph nodes.

Tamburini B, Sheridan R, Doan T, Lucas C, Forward T, Fleming I Res Sq. 2024; .

PMID: 39711554 PMC: 11661310. DOI: 10.21203/rs.3.rs-5493746/v1.


Inflammation switches the chemoattractant requirements for naive lymphocyte entry into lymph nodes.

Chen K, De Giovanni M, Xu Y, An J, Kirthivasan N, Lu E Cell. 2024; 188(4):1019-1035.e22.

PMID: 39708807 PMC: 11845304. DOI: 10.1016/j.cell.2024.11.031.


Deep mutationally scanned (DMS) CHIKV E3/E2 virus library maps viral amino acid preferences and predicts viral escape mutants of neutralizing CHIKV antibodies.

Stumpf M, Brunetti T, Davenport B, McCarthy M, Morrison T bioRxiv. 2024; .

PMID: 39677653 PMC: 11643203. DOI: 10.1101/2024.12.04.626854.


Pathogenicity and virulence of chikungunya virus.

Freppel W, Silva L, Stapleford K, Herrero L Virulence. 2024; 15(1):2396484.

PMID: 39193780 PMC: 11370967. DOI: 10.1080/21505594.2024.2396484.


Elevated Complement Activation Fragments and C1q-Binding Circulating Immune Complexes in Varied Phases of Chikungunya Virus Infection.

Kasbe R, Tripathy A, Wani M, Mullick J Curr Microbiol. 2024; 81(8):242.

PMID: 38913141 DOI: 10.1007/s00284-024-03732-7.


References
1.
Sissoko D, Malvy D, Ezzedine K, Renault P, Moscetti F, Ledrans M . Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period. PLoS Negl Trop Dis. 2009; 3(3):e389. PMC: 2647734. DOI: 10.1371/journal.pntd.0000389. View

2.
Hawman D, Stoermer K, Montgomery S, Pal P, Oko L, Diamond M . Chronic joint disease caused by persistent Chikungunya virus infection is controlled by the adaptive immune response. J Virol. 2013; 87(24):13878-88. PMC: 3838294. DOI: 10.1128/JVI.02666-13. View

3.
Berg E, Robinson M, Warnock R, Butcher E . The human peripheral lymph node vascular addressin is a ligand for LECAM-1, the peripheral lymph node homing receptor. J Cell Biol. 1991; 114(2):343-9. PMC: 2289069. DOI: 10.1083/jcb.114.2.343. View

4.
Ozden S, Huerre M, Riviere J, Coffey L, Afonso P, Mouly V . Human muscle satellite cells as targets of Chikungunya virus infection. PLoS One. 2007; 2(6):e527. PMC: 1885285. DOI: 10.1371/journal.pone.0000527. View

5.
Suresh M, Lanier G, Large M, Whitmire J, Altman J, Ruddle N . Role of lymphotoxin alpha in T-cell responses during an acute viral infection. J Virol. 2002; 76(8):3943-51. PMC: 136110. DOI: 10.1128/jvi.76.8.3943-3951.2002. View